R. K. Choudhary

R. K. Choudhary

Associate Professsor College of Applied and Health Sciences

Contact Details
Job Title
Associate Professsor
College
College of Applied and Health Sciences

Dr. Ranjay Kumar Choudhary is an accomplished academician, biomedical researcher, and healthcare professional with over two decades of experience in higher education, translational research, curriculum development, laboratory quality management, and clinical diagnostics across India, Saudi Arabia, and Oman. Holding a PhD in Medical Laboratory Technology and an MBA in Education Management, he has served in progressive academic leadership roles, including Professor, Head of Department, and Quality Lead. He has taught diverse courses in medical laboratory sciences, supervised 30 master’s dissertations and three PhD theses, and mentored numerous students in research and professional development. His multidisciplinary research spans infectious diseases, molecular diagnostics, immunology, metabolic disorders, microbiome science, natural product therapeutics, extracellular vesicles, and precision medicine, with notable contributions to HIV diagnostics, transfusion-transmitted infections, COVID-19 predictors, cancer signaling pathways, neuroprotection, PCOS, metabolic syndrome, and AI-driven immunotherapy. He has completed several funded projects, published extensively in Scopus and Web of Science-indexed journals, and secured multiple patents for innovative diagnostic technologies. A licensed Specialist Laboratory Scientist and certified internal auditor, Dr. Choudhary is also experienced in OBE-driven curriculum design, accreditation standards (NCAAA, ABET, AHPGS, NAAC), and laboratory QA/QC systems. He continues to contribute actively to advancing medical laboratory sciences and interdisciplinary biomedical research at regional and global levels.

Diploma, Bachelor, Master, PhD in Medical Laboratory Sciences, MBA in Education Management 

Dr. Ranjay Kumar Choudhary is a multidisciplinary biomedical researcher with extensive contributions across infectious diseases, molecular diagnostics, immunology, metabolic disorders, microbiome science, natural product therapeutics, and advanced biomedical technologies. His research focuses on understanding molecular and inflammatory mechanisms of disease and translating these insights into innovative diagnostic and therapeutic solutions with strong translational and public health relevance.

He has made significant contributions to infectious disease research, particularly in HIV diagnostics, transfusion-transmitted infections, and COVID-19 clinical predictors. His work on natural metabolites and medicinal plants has provided important mechanistic insights into cancer signaling, chemoprevention, and neuroprotective strategies, including nitric oxide synthase inhibition. Dr. Choudhary’s research also addresses metabolic and inflammatory disorders such as PCOS, metabolic syndrome, and gut–inflammation–microbiome interactions.

In immunology, he has advanced understanding of cytokine networks, autoimmune mechanisms, and AI-driven approaches to personalized immunotherapy. His expertise extends to modern molecular diagnostics, including exosomal RNA biomarkers, advanced healthcare diagnostic platforms, bioinformatics, molecular docking, and precision medicine technologies. He has also contributed to extracellular vesicle research, exploring their roles in cancer progression, drug delivery, and vaccine development.

Additional contributions include work on cardiovascular and neurological disorders, network pharmacology approaches, forensic toxicology, and emergency diagnostic innovations. Across his publications, Dr. Choudhary demonstrates strong methodological expertise in molecular biology, biomarker discovery, natural compound pharmacology, microbiome analytics, and translational research design. His body of work, published in reputable international journals, spans basic, clinical, and applied biomedical research, with growing impact in emerging fields such as exosomes and AI-assisted healthcare.

Journal paper

2026 Targeting Cancer Stem Cells with Phytochemicals: Molecular Mechanisms and Therapeutic Potential 10.3390/biomedicines14010215
2026 Journey through the gut-inflammation axis in polycystic ovary syndrome: the microbiota’s role in shaping inflammatory pathways https://doi.org/10.1007/s11010-025-05409-6
2025 Advancements in the treatment of autoimmune diseases: Integrating artificial intelligence for personalized medicine https://doi.org/10.24294/ti8970
2025 Male Breast Cancer: Epidemiology, Diagnosis, Molecular Mechanisms, Therapeutics, and Future Prospective 10.32604/or.2025.068238
2025 Natural Metabolites as Modulators of Sensing and Signaling Mechanisms: Unlocking Anti-Ovarian Cancer Potential https://doi.org/10.3390/biomedicines13081830
2025 Network Pharmacology Approaches to Myocardial Infarction Reperfusion Injury: Exploring Mechanisms, Pathophysiology, and Novel Therapies https://doi.org/10.3390/biomedicines13071532
2025 Innovative Diagnostic Approaches and Challenges in the Management of HIV: Bridging Basic Science and Clinical Practice https://doi.org/10.3390/life15020209
2025 Innovative Strategies in the Diagnosis and Treatment of Liver Cirrhosis and Associated Syndromes https://doi.org/10.3390/life15050779
2025 Carbon Monoxide Poisoning: Diagnosis, Prognostic Factors, Treatment Strategies, and Future Perspectives https://doi.org/10.3390/diagnostics15050581
2025 Role of artificial intelligence and personalized medicine in enhancing HIV management and treatment outcomes https://doi.org/10.3390/life15050745
2025 Carbon monoxide poisoning: Diagnosis, prognostic factors, treatment strategies, and future innovations. https://doi.org/10.3390/diagnostics15050581
2025 Innovative diagnostic approaches and challenges in the management of HIV. Life, 15(2), 209. https://doi.org/10.3390/life15020209
2025 Carbon monoxide poisoning: Diagnosis, prognostic factors, treatment strategies, and future perspectives. Diagnostics, 15(5), 581. https://doi.org/10.3390/life15020209
2022 Therapeutic potential of nitric oxide synthase inhibitor from natural sources for the treatment of ischemic stroke https://doi.org/10.1016/j.sjbs.2021.10.003
2022 Assessment of IL-1β, IL-6, TNF-α, IL-8, and CCL 5 levels in newly diagnosed Saudi patients with rheumatoid arthritis https://doi.org/10.1111/1756-185X.14373Digital Object Identifier (DOI)
2022 Pioneer Role of Extracellular Vesicles as Modulators of Cancer Initiation in Progression, Drug Therapy, and Vaccine Prospects https://doi.org/10.3390/cells11030490
2022 Plants in Anticancer Drug Discovery: From Molecular Mechanism to Chemoprevention https://doi.org/10.1155/2022/5425485
2021 Analysis between Cigarette and Shisha Smokers for Early Atherogenesis: A Cardiovascular Disease DOI: 10.9734/JPRI/2021/v33i41A32316
2021 Clinical characteristics and predictors of mortality among COVID-19 patients in Saudi Arabia https://doi.org/10.1016/j.jiph.2021.06.005
2018 The prevalence of transfusion-transmitted infections and nucleic acid testing among blood donors in Majmaah, Saudi Arabia https://doi.org/10.1016/j.jiph.2018.04.008

Registered professional license from Saudi commission of health specialist Designation: Specialist Laboratory License number- 15-RA-00-46072.

Certified Internal auditor of OHSAS: 80001:2007. From TUV SUD Middle east L.L.C. 


Registered professional license from Uttarakhand Paramedical council, Dehradun. Laboratory License number- 3845/315 MLT.